“AMD is a leading cause of vision loss in Americans age 50 and older. For my patients who are diagnosed with moderate to advanced AMD, I typically recommend a plan that includes regular exercise, a healthy diet, and PreserVision – a supplement that contains nutrients recommended by the National Eye Institute to help reduce the risk of AMD progression in these patients,” said Rishi Singh, M.D., Cole Eye Institute, Cleveland Clinic. “I am pleased to recommend the new PreserVision AREDS 2 minigels to my patients who have inquired about options that could be easier for them to swallow.”
It is estimated that as many as 16 million people in the United States have AMD. In its early stages, AMD may not present any symptoms, therefore patients may not think to consult with their eye care professional—leaving opportunity for the condition to advance. Left untreated, AMD has the potential to lead to severe vision loss or blindness.
“We are dedicated to providing eye care professionals and their patients with products that help address their needs,” said Chris Marschall, vice president and general manager, U.S. Consumer Health Care, Bausch + Lomb. “The PreserVision AREDS 2 Formula minigel eye vitamins will provide patients with a new easier-to-swallow1 option that they can incorporate as part of their doctor-recommended plan.”
PreserVision AREDS 2 minigel eye vitamins are available at major retailers nationwide in the vitamin aisle and have a suggested retail price of $32.99 (120-count bottle).